Researchers find weakness in hep C virus

Researchers from the University of New South Wales say they've discovered not one but two "Achilles heels" within the hepatitis C virus. The diseases' first weak point is in transmission, when it must move from person to person. The second comes three months after infection; the number of viral variants drops as the immune system responds, providing a window that may make it easier to target the virus. Article

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.